cyclacel.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | Cyclacel Pharmaceuticals, Inc. - Harnessing the cell cycle to treat cancer and other serious |
| Description | Harnessing the cell cycle to treat cancer and other serious diseases About Cyclacel As a clinical-stage, biopharmaceutical company, we develop innovative ca |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 107.180.3.235 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cyclacel.com Valuation
|
US$9,153,509
Last updated: 2023-05-03 05:58:53
cyclacel.com has Semrush global rank of 1,156,311. cyclacel.com has an estimated worth of US$ 9,153,509, based on its estimated Ads revenue. cyclacel.com receives approximately 1,056,175 unique visitors each day. Its web server is located in United States, with IP address 107.180.3.235. According to SiteAdvisor, cyclacel.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,153,509 |
| Daily Ads Revenue | US$8,450 |
| Monthly Ads Revenue | US$253,482 |
| Yearly Ads Revenue | US$3,041,782 |
| Daily Unique Visitors | 70,412 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cyclacel.com. | A | 299 | IP: 107.180.3.235 |
| cyclacel.com. | NS | 14400 | NS Record: ns1.dreamhost.com. |
| cyclacel.com. | NS | 14400 | NS Record: ns3.dreamhost.com. |
| cyclacel.com. | NS | 14400 | NS Record: ns2.dreamhost.com. |
| cyclacel.com. | MX | 300 | MX Record: 10 cyclacel-com.mail.protection.outlook.com. |
| cyclacel.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| cyclacel.com. | TXT | 300 | TXT Record: MS=ms89300122 |
HtmlToTextCheckTime:2023-05-03 05:58:53
| Search … Careers Contact Us About Us Menu Toggle Leadership Board of Directors Our Science Menu Toggle Overview Fadraciclib Plogosertib Publications Pipeline News Investors Search … Main Menu Harnessing the cell cycle to treat cancer and other serious diseases About Cyclacel As a clinical-stage, biopharmaceutical company, we develop innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology. Cyclacel’s strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates to address oncology and hematology indications. Who We Are Our Science Cyclacel is a pioneer in the field of cell cycle biology to treat cancer. We use insights in cancer biology to research and develop medicines that address the growing problem of resistance. Cancer cells learn to evade anticancer therapeutics and become resistant to available therapies. We aim to suppress mechanisms of resistance and reactivate the body’s own cell death |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 144 Content-Type: text/html; charset=UTF-8 Location: https://cyclacel.com/ Server: Microsoft-IIS/8.5 X-Powered-By: ASP.NET X-Powered-By-Plesk: PleskWin Date: Mon, 25 Oct 2021 12:56:16 GMT HTTP/1.1 200 OK Content-Length: 16112 Content-Type: text/html Server: Microsoft-IIS/8.5 X-Powered-By: ASP.NET X-Powered-By-Plesk: PleskWin Date: Mon, 25 Oct 2021 12:56:16 GMT |
cyclacel.com Whois Information
Domain Name: CYCLACEL.COM Registry Domain ID: 3985038_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2019-06-10T08:06:52Z Creation Date: 1997-09-04T04:00:00Z Registry Expiry Date: 2022-09-03T04:00:00Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.DREAMHOST.COM Name Server: NS2.DREAMHOST.COM Name Server: NS3.DREAMHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T16:24:04Z <<< |